,,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'enhertu']
#breastcancer drug trial results in unheard-of survival rates. for some patients with metastatic tumors not significantly affected by other forms of chemotherapy, the treatment, #enhertu, halted their cancer s growth, by via #asco22
André Picard is the health columnist at The Globe and Mail. Author of  the bestselling book "NEGLECTED NO MORE".